Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Subacute endocarditis is a serious infection often caused by viridans group streptococci.
• Vancomycin at bacteriostatic concentrations has shown efficacy in preventing endocarditis in a rat model.
• Understanding alternative antibiotic strategies is crucial for effective endocarditis prophylaxis.

Purpose of the Study:

• To evaluate the efficacy of three bacteriostatic antibiotics (clindamycin, erythromycin, doxycycline) against common streptococcal species causing endocarditis.
• To determine if non-bactericidal antibiotic concentrations can prevent experimental endocarditis.
• To investigate the mechanism of antibiotic action in endocarditis prophylaxis.

Main Methods:

• A rat model of endocarditis was established using intracardiac catheterization and intravenous challenge with Streptococcus species.
• Rats received single intravenous doses of clindamycin, erythromycin, or doxycycline.
• Antibiotic serum levels and efficacy in preventing endocarditis were assessed.

Main Results:

• Significant protection against endocarditis was observed with all three tested antibiotics.
• Clindamycin demonstrated full efficacy against Streptococcus intermedius, Streptococcus sanguis, and Streptococcus mitior at human-achievable doses.
• Antibiotic concentrations preventing endocarditis were below minimal bactericidal concentrations, and serum was not bactericidal at the time of challenge.

Conclusions:

• Bacteriostatic concentrations of clindamycin, erythromycin, and doxycycline can prevent experimental streptococcal endocarditis in rats.
• Clindamycin is a promising agent for endocarditis prophylaxis due to its broad efficacy.
• The prevention of endocarditis by these antibiotics occurs through mechanisms independent of direct bacterial killing.